No | 55% (39%, 71%) [18] | 46% (29%, 62%) [14] | 21% (6.7%, 36%) [6] |
|
|
Yes | 33% (24%, 43%) [27] | 25% (16%, 34%) [17] | 13% (4.8%, 20%) [6] |
|
|
Tumor size >8cm |
|
|
| 0.4963 | 0.1527 |
No | 44% (33%, 54%) [34] | 37% (27%, 47%) [26] | 15% (6.3%, 23%) [9] |
|
|
Yes | 35% (24%, 46%) [22] | 25% (15%, 35%) [14] | 13% (4.6%, 22%) [6] |
|
|
Extension level 2/3 vs 1 |
|
|
| 0.9825 | 0.8944 |
No | 40% (31%, 49%) [40] | 34% (25%, 43%) [32] | 18% (10%, 26%) [14] |
|
|
Yes | 41% (23%, 60%) [10] | 33% (15%, 51%) [6] | 5.5% (4.8%, 16%) [1] |
|
|
Positive lymph nodes |
|
|
| <0.0001 | <0.01 |
No | 45% (36%, 53%) [52] | 37% (28%, 45%) [38] | 17% (10%, 24%) [15] |
|
|
Yes | 10% (0%, 21%) [3] | 3% (0%, 10%) [0] | 0% |
|
|
Peri-nephric fat involvement |
|
|
| 0.0010 | 0.0035 |
No | 51% (41%, 61%) [42] | 44% (33%, 54%) [33] | 21% (12%, 30%) [13] |
|
|
Yes | 25% (15%, 35%) [16] | 16% (7.3%, 25%) [9] | 7.2% (0.6%, 14%) [4] |
|
|
Metastasis at surgery |
|
|
| 0.1758 | 0.7074 |
No | 42% (34%, 50%) [52] | 34% (26%, 42%) [39] | 16% (9.6%, 23%) [16] |
|
|
Yes | 26% (8.4%, 43%) [6] | 21% (4.1%, 37%) [3] |
|
|
|
Positive surgical margin |
|
|
| 0.1583 | 0.2591 |
No | 49% (39%, 59%) [39] | 39% (29%, 49%) [29] | 19% (9.7%, 27%) [12] |
|
|
Yes | 37% (22%, 51%) [14] | 34% (19%, 49%) [10] | 10% (0.4%, 21%) [3] |
|
|